<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="legius" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">legius</book-part-id>
      <title-group>
        <title>Legius Syndrome</title>
        <alt-title alt-title-type="alt-title">Synonym: Neurofibromatosis Type 1-Like Syndrome</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Stevenson</surname>
            <given-names>David</given-names>
          </name>
          <degrees>MD</degrees>
          <aff>Stanford University<break/>Stanford, California</aff>
          <email>dasteven@stanford.edu</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Viskochil</surname>
            <given-names>David</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <aff>University of Utah<break/>Salt Lake City, Utah</aff>
          <email>dave.viskochil@hsc.utah.edu</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Mao</surname>
            <given-names>Rong</given-names>
          </name>
          <degrees>MD</degrees>
          <aff>University of Utah<break/>Salt Lake City, Utah</aff>
          <email>rong.mao@aruplab.com</email>
        </contrib>
      </contrib-group>
      <pub-history>
        <date date-type="created">
          <day>14</day>
          <month>10</month>
          <year>2010</year>
        </date>
        <date date-type="updated">
          <day>15</day>
          <month>1</month>
          <year>2015</year>
        </date>
        <date date-type="revised">
          <day>12</day>
          <month>5</month>
          <year>2011</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="lhon" document-type="chapter">Leber Hereditary Optic Neuropathy</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="lenz" document-type="chapter">Lenz Microphthalmia Syndrome</related-object>
      <abstract id="legius.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>Legius syndrome is characterized by multiple caf&#x000e9; au lait macules without neurofibromas or other tumor manifestations of neurofibromatosis type 1 (NF1). Additional clinical manifestations reported commonly include intertriginous freckling, lipomas, macrocephaly, and learning disabilities / ADHD / developmental delays. Current knowledge of the natural history of Legius syndrome is based on the clinical manifestations of fewer than 200 individuals with a molecularly confirmed diagnosis; better delineation of the clinical manifestations and natural history of Legius syndrome will likely occur as more affected individuals are identified.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>The diagnosis of Legius syndrome is difficult to make on clinical grounds alone. Detection of a pathogenic variant in <italic toggle="yes">SPRED1</italic>, the only gene known to be associated with Legius syndrome, is necessary to confirm the diagnosis.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> Consideration of behavioral modification and/or pharmacologic therapy for those with ADHD; physical, speech, and occupational therapy for those with identified developmental delays; individualized education plans for those with learning disorders.</p>
          <p><italic toggle="yes">Surveillance:</italic> Routine screening for developmental delays and behavioral and learning problems.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>Legius syndrome is inherited in an autosomal dominant manner. Each child of an individual with Legius syndrome has a 50% chance of inheriting the pathogenic variant. Although uncommonly requested, prenatal diagnosis for pregnancies at increased risk is possible if the <italic toggle="yes">SPRED1</italic> pathogenic variant has been identified in an affected family member.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="legius.Diagnosis">
        <title>Diagnosis</title>
        <sec id="legius.Suggestive_Findings">
          <title>Suggestive Findings</title>
          <p>Diagnosis of Legius syndrome should be suspected in an individual who:</p>
          <list list-type="bullet">
            <list-item>
              <p>Has pigmentary dysplasia consisting of caf&#x000e9; au lait macules, with or without intertriginous freckling; and</p>
            </list-item>
            <list-item>
              <p>Lacks the non-pigmentary clinical diagnostic manifestations of neurofibromatosis type 1 (NF1) (e.g., Lisch nodules, neurofibromas, optic nerve glioma, sphenoid wing dysplasia, long bone dysplasia); and</p>
            </list-item>
            <list-item>
              <p>Has a parent with multiple caf&#x000e9; au lait macules but no other features of NF1.</p>
            </list-item>
          </list>
          <p>Additional clinical manifestations reported in multiple individuals are listed in <xref ref-type="table" rid="legius.T.additional_findings_reported_in">Table 2</xref>.</p>
        </sec>
        <sec id="legius.Establishing_the_Diagnosis">
          <title>Establishing the Diagnosis</title>
          <p>The diagnosis of Legius syndrome is established in a proband with the identification of a heterozygous pathogenic variant in <italic toggle="yes">SPRED1</italic> (see <xref ref-type="table" rid="legius.T.summary_of_molecular_genetic_te">Table 1</xref>).</p>
          <p>
            <bold>Molecular testing approaches can include:</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Sequence analysis of <italic toggle="yes">SPRED1</italic> first, followed by deletion/duplication analysis if no pathogenic variant is found;</p>
            </list-item>
            <list-item>
              <p>Use of a multi-gene panel that includes <italic toggle="yes">SPRED1</italic> and other genes of interest (see <xref ref-type="sec" rid="legius.Differential_Diagnosis">Differential Diagnosis</xref>). Note: The genes included and the methods used in multi-gene panels vary by laboratory and over time.</p>
            </list-item>
          </list>
          <p>Note: Opinions differ on the appropriate approach when clinical information and family history cannot distinguish between NF1 and Legius syndrome. The assessment of pros and cons of molecular testing requires consideration of the circumstances unique to each individual, including (but not limited to) the following:</p>
          <list list-type="bullet">
            <list-item>
              <p>Clinical findings and family history</p>
            </list-item>
            <list-item>
              <p>Age of the individual</p>
            </list-item>
            <list-item>
              <p>Differences in recommended clinical management when the diagnosis of NF1 or Legius syndrome is established with certainty versus when the diagnosis of neither can be established with confidence</p>
            </list-item>
            <list-item>
              <p>Psychological burden of a diagnosis or lack thereof</p>
            </list-item>
            <list-item>
              <p>Costs of testing and surveillance</p>
            </list-item>
          </list>
          <p>For various approaches, see <xref ref-type="bibr" rid="legius.REF.messiaen.2009.2111">Messiaen et al [2009]</xref>, <xref ref-type="bibr" rid="legius.REF.pasmant.2009.1131">Pasmant et al [2009]</xref>, <xref ref-type="bibr" rid="legius.REF.stevenson.2009.2150">Stevenson &#x00026; Viskochil [2009]</xref>, <xref ref-type="bibr" rid="legius.REF.muramzborovski.2010.1203">Muram-Zborovski et al [2010]</xref>, <xref ref-type="bibr" rid="legius.REF.denayer.2011a.e1985">Denayer et al [2011a]</xref>, <xref ref-type="bibr" rid="legius.REF.brems.2012.1538">Brems et al [2012]</xref>.</p>
          <table-wrap id="legius.T.summary_of_molecular_genetic_te" orientation="portrait" position="anchor">
            <label>Table 1. </label>
            <caption>
              <p>Summary of Molecular Genetic Testing Used in Legius Syndrome</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_legius.T.summary_of_molecular_genetic_te_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene&#x000a0;<sup>1</sup></th>
                  <th id="hd_h_legius.T.summary_of_molecular_genetic_te_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Test Method</th>
                  <th id="hd_h_legius.T.summary_of_molecular_genetic_te_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Proportion of Probands with a Pathogenic Variant Detectable by This Method</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_legius.T.summary_of_molecular_genetic_te_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">
                    <italic toggle="yes">SPRED1</italic>
                  </td>
                  <td headers="hd_h_legius.T.summary_of_molecular_genetic_te_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>2</sup></td>
                  <td headers="hd_h_legius.T.summary_of_molecular_genetic_te_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">88%&#x000a0;<sup>3</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_legius.T.summary_of_molecular_genetic_te_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Deletion/duplication analysis&#x000a0;<sup>4</sup></td>
                  <td headers="hd_h_legius.T.summary_of_molecular_genetic_te_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">10%&#x000a0;<sup>5</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_legius.T.summary_of_molecular_genetic_te_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Unknown&#x000a0;<sup>6</sup></td>
                  <td headers="hd_h_legius.T.summary_of_molecular_genetic_te_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">NA</td>
                  <td headers="hd_h_legius.T.summary_of_molecular_genetic_te_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1"/>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="legius.TF.1.1">
                <label>1. </label>
                <p>See <related-object source-id="gene" document-id="legius" object-id="legius.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein. See <xref ref-type="sec" rid="legius.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants detected in this gene.</p>
              </fn>
              <fn id="legius.TF.1.2">
                <label>2. </label>
                <p>Sequence analysis detects variants that are benign, likely benign, of uncertain significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
              </fn>
              <fn id="legius.TF.1.3">
                <label>3. </label>
                <p>Of individuals evaluated for NF1 without an identifiable <italic toggle="yes">NF1</italic> pathogenic variant, 3%-25% had an identifiable <italic toggle="yes">SPRED1</italic> pathogenic variant [<xref ref-type="bibr" rid="legius.REF.brems.2007.1120">Brems et al 2007</xref>, <xref ref-type="bibr" rid="legius.REF.messiaen.2009.2111">Messiaen et al 2009</xref>, <xref ref-type="bibr" rid="legius.REF.pasmant.2009.1131">Pasmant et al 2009</xref>, <xref ref-type="bibr" rid="legius.REF.spurlock.2009.431">Spurlock et al 2009</xref>]. Sequence analysis should identify the majority of individuals without whole gene deletions, although it is estimated that approximately 1%-2% could have deep intronic variants which could be missed, but this has not been reported.</p>
              </fn>
              <fn id="legius.TF.1.4">
                <label>4. </label>
                <p>Testing that identifies exon or whole-gene deletions/duplications not detectable by sequence analysis of the coding and flanking intronic regions of genomic DNA. Included in the variety of methods that may be used are: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and chromosomal microarray (CMA) that includes this gene/chromosome segment.</p>
              </fn>
              <fn id="legius.TF.1.5">
                <label>5. </label>
                <p><xref ref-type="bibr" rid="legius.REF.spencer.2011.1352">Spencer et al [2011]</xref> report that deletions comprise approximately 10% of <italic toggle="yes">SPRED1</italic> pathogenic variants and include multiexon deletions and whole <italic toggle="yes">SPRED1</italic> gene deletions</p>
              </fn>
              <fn id="legius.TF.1.6">
                <label>6. </label>
                <p><xref ref-type="bibr" rid="legius.REF.messiaen.2009.2111">Messiaen et al [2009]</xref> reported on a cohort of familial cases with similar phenotypes and 73% had pathogenic variants in <italic toggle="yes">NF1</italic> and 19% had a <italic toggle="yes">SPRED1</italic> pathogenic variant, suggesting that other loci are possible for an overlapping pigmentary phenotype. In addition, several families with multiple caf&#x000e9; au lait macules inherited in an autosomal dominant pattern have been described [<xref ref-type="bibr" rid="legius.REF.brunner.1993.472">Brunner et al 1993</xref>, <xref ref-type="bibr" rid="legius.REF.charrow.1993.606">Charrow et al 1993</xref>, <xref ref-type="bibr" rid="legius.REF.arnsmeier.1994.1425">Arnsmeier et al 1994</xref>, <xref ref-type="bibr" rid="legius.REF.abeliovich.1995.985">Abeliovich et al 1995</xref>, <xref ref-type="bibr" rid="legius.REF.nystr_m.2009b.693">Nystr&#x000f6;m et al 2009b</xref>].</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
      </sec>
      <sec id="legius.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="legius.Clinical_Description">
          <title>Clinical Description</title>
          <p>The natural history of Legius syndrome is based on the clinical manifestations of a few series of individuals with <italic toggle="yes">SPRED1</italic> pathogenic variants and their extended families. Additional less common manifestations are listed in <xref ref-type="table" rid="legius.T.additional_findings_reported_in">Table 2</xref>. Better delineation of the clinical manifestations and natural history of Legius syndrome will likely occur as more affected individuals are identified and followed prospectively.</p>
          <p>Of note, the phenotype of Legius syndrome is based on the reports of relatively few (&#x0003c;200) individuals, in which the primary focus was on individuals with the overlapping pigmentary manifestations of <related-object link-type="booklink" source-id="gene" document-id="nf1" document-type="chapter">neurofibromatosis type 1</related-object> (NF1).</p>
          <p><bold>Skin findings.</bold> Almost invariably, individuals with Legius syndrome present with caf&#x000e9; au lait macules. In some instances, freckling of the axillary/groin region is present. Two individuals (a male age 60 years and a child age 2 years), each with a presumed pathogenic <italic toggle="yes">SPRED1</italic> variant, have been reported with no caf&#x000e9; au lait macules or freckling [<xref ref-type="bibr" rid="legius.REF.brems.2007.1120">Brems et al 2007</xref>, <xref ref-type="bibr" rid="legius.REF.messiaen.2009.2111">Messiaen et al 2009</xref>]. The lack of pigmentary manifestations in the two-year-old was possibly a result of the child&#x02019;s young age. The number of caf&#x000e9; au lait macules increases with age in childhood, similar to what is observed in NF1 [Author, personal observation].</p>
          <p><bold>Macrocephaly.</bold> Absolute or relative macrocephaly has been seen in children and adults with Legius syndrome. However, the frequency of macrocephaly varied in different reports: head circumference was at or above the 97th centile in approximately 40% of individuals in one cohort [<xref ref-type="bibr" rid="legius.REF.brems.2007.1120">Brems et al 2007</xref>] but above the 95th centile in only one of 18 individuals in another cohort [<xref ref-type="bibr" rid="legius.REF.pasmant.2009.1131">Pasmant et al 2009</xref>].</p>
          <p><bold>Stature.</bold> Absolute short stature has not been frequently noted in most series (although <xref ref-type="bibr" rid="legius.REF.denayer.2011a.e1985">Denayer et al [2011a]</xref> reported it in 31%). <xref ref-type="bibr" rid="legius.REF.brems.2007.1120">Brems et al [2007]</xref> reported that in 52% of individuals, height was greater than the 50th centile. Growth charts for Legius syndrome have not been published.</p>
          <p><bold>Neurobehavioral and developmental problems</bold> are observed in individuals with Legius syndrome, but in many instances detailed descriptions are lacking. <xref ref-type="bibr" rid="legius.REF.messiaen.2009.2111">Messiaen et al [2009]</xref> reported three individuals who had hyperactivity and two who had attention deficits. Of the six individuals with developmental abnormalities described by <xref ref-type="bibr" rid="legius.REF.messiaen.2009.2111">Messiaen et al [2009]</xref>, all had speech and/or language delays as the primary or only delay. In the 12 individuals with Legius syndrome described by <xref ref-type="bibr" rid="legius.REF.spurlock.2009.431">Spurlock et al [2009]</xref>, no learning or developmental problems were noted in the probands. <xref ref-type="bibr" rid="legius.REF.denayer.2011a.e1985">Denayer et al [2011a]</xref> described five children with motor delay and five with speech delay, three individuals with ADHD, and 14 of 25 individuals with learning difficulties.</p>
          <p>The cognitive phenotype in Legius syndrome is likely milder than that observed in NF1. A study of 15 individuals with Legius syndrome by <xref ref-type="bibr" rid="legius.REF.denayer.2011b.123">Denayer et al [2011b]</xref> showed a lower performance IQ in children with Legius syndrome compared to their unaffected family members, although the full-scale IQ did not differ. <xref ref-type="bibr" rid="legius.REF.laycockvan_spyk.2011.93">Laycock-van Spyk et al [2011]</xref> reported one individual with cognitive impairment with an IQ of 68.</p>
          <p><bold>Brain imaging.</bold> Two individuals had T<sub>2</sub> hyperintense lesions on brain imaging; thus, the presence of such lesions cannot be used to differentiate between Legius syndrome and NF1 [<xref ref-type="bibr" rid="legius.REF.denayer.2011a.e1985">Denayer et al 2011a</xref>].</p>
          <p><bold>Vascular anomalies.</bold> A small number of vascular anomalies have been reported, but the descriptions are incomplete and different in each instance. The vascular abnormalities were listed as &#x0201c;tuberous hemangioma,&#x0201d; &#x0201c;inguinal hemangioma,&#x0201d; &#x0201c;large right temporal venous anomaly in brain,&#x0201d; and &#x0201c;vascular anomaly left lower leg.&#x0201d; Additional data are needed to determine if these reported vascular anomalies are tumors or malformations, and whether there is an increase of vascular anomalies in Legius syndrome.</p>
          <p><bold>Other.</bold> See <xref ref-type="table" rid="legius.T.additional_findings_reported_in">Table 2</xref>. Examples of other findings reported in isolated or only a few individuals include fifth finger clinodactyly, Chiari I malformation, hypotonia, cataract, nephrolithiasis, urethral meatal stenosis, pulmonic stenosis and mitral valve prolapse, paroxysmal atrial tachycardia, tubular colonic adenoma, progressive dystonia, xanthelasmas, desmoid tumor, vestibular schwanomma, tenosynovial giant cell tumor, dermoid tumor of the ovary, non-small cell lung cancer, Wilms tumor, and monoblastic acute leukemia. Observations of clinical findings in a single individual should be taken with caution because chance occurrence cannot be distinguished from specific disease associations.</p>
          <table-wrap id="legius.T.additional_findings_reported_in" orientation="portrait" position="anchor">
            <label>Table 2. </label>
            <caption>
              <p>Additional Findings Reported in Multiple Individuals in Studies of Legius Syndrome</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_legius.T.additional_findings_reported_in_1_1_1_1" rowspan="3" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_1">Finding</th>
                  <th id="hd_h_legius.T.additional_findings_reported_in_1_1_1_2" valign="middle" colspan="8" align="left" scope="colgroup" rowspan="1">Study</th>
                </tr>
                <tr>
                  <th headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2" id="hd_h_legius.T.additional_findings_reported_in_1_1_2_1" valign="middle" colspan="1" align="left" scope="colgroup" rowspan="1"><xref ref-type="bibr" rid="legius.REF.brems.2007.1120">Brems et al [2007]</xref> (n=44)</th>
                  <th headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2" id="hd_h_legius.T.additional_findings_reported_in_1_1_2_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1"><xref ref-type="bibr" rid="legius.REF.pasmant.2009.1131">Pasmant et al [2009]</xref> (n=18)</th>
                  <th headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2" id="hd_h_legius.T.additional_findings_reported_in_1_1_2_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1"><xref ref-type="bibr" rid="legius.REF.spurlock.2009.431">Spurlock et al [2009]</xref> (n=12)</th>
                  <th headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2" id="hd_h_legius.T.additional_findings_reported_in_1_1_2_4" valign="middle" align="left" scope="col" rowspan="1" colspan="1"><xref ref-type="bibr" rid="legius.REF.messiaen.2009.2111">Messiaen et al [2009]</xref> (n=40)&#x000a0;<sup>1</sup></th>
                  <th headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2" id="hd_h_legius.T.additional_findings_reported_in_1_1_2_5" valign="middle" align="left" scope="col" rowspan="1" colspan="1"><xref ref-type="bibr" rid="legius.REF.muramzborovski.2010.1203">Muram-Zborovski et al [2010]</xref> (n=2)</th>
                  <th headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2" id="hd_h_legius.T.additional_findings_reported_in_1_1_2_6" valign="middle" align="left" scope="col" rowspan="1" colspan="1"><xref ref-type="bibr" rid="legius.REF.denayer.2011a.e1985">Denayer et al [2011a]</xref> (n=30)</th>
                  <th headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2" id="hd_h_legius.T.additional_findings_reported_in_1_1_2_7" valign="middle" align="left" scope="col" rowspan="1" colspan="1"><xref ref-type="bibr" rid="legius.REF.spencer.2011.1352">Spencer et al [2011]</xref> (n=7)</th>
                  <th headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2" id="hd_h_legius.T.additional_findings_reported_in_1_1_2_8" valign="middle" align="left" scope="col" rowspan="1" colspan="1"><xref ref-type="bibr" rid="legius.REF.laycockvan_spyk.2011.93">Laycock-van Spyk et al [2011]</xref> (n=10)</th>
                </tr>
                <tr>
                  <th headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_1 hd_h_legius.T.additional_findings_reported_in_1_1_2_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_3 hd_h_legius.T.additional_findings_reported_in_1_1_2_4 hd_h_legius.T.additional_findings_reported_in_1_1_2_5 hd_h_legius.T.additional_findings_reported_in_1_1_2_6 hd_h_legius.T.additional_findings_reported_in_1_1_2_7 hd_h_legius.T.additional_findings_reported_in_1_1_2_8" id="hd_h_legius.T.additional_findings_reported_in_1_1_3_1" valign="middle" colspan="8" align="left" scope="colgroup" rowspan="1">Number of persons by study in whom the finding was observed&#x000a0;<sup>2</sup></th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>Macrocephaly</bold>
                  </td>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_1 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" valign="middle" align="left" rowspan="1" colspan="1">13</td>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_2 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" valign="middle" align="left" rowspan="1" colspan="1">1</td>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_3 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" valign="middle" align="left" rowspan="1" colspan="1">1</td>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_4 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" valign="middle" align="left" rowspan="1" colspan="1">8</td>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_5 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" valign="middle" align="left" rowspan="1" colspan="1">1</td>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_6 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" valign="middle" align="left" rowspan="1" colspan="1">1</td>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_7 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_8 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" valign="middle" align="left" rowspan="1" colspan="1">3</td>
                </tr>
                <tr>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>Short stature (&#x0003c;5th centile)</bold>
                  </td>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_1 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" valign="middle" align="left" rowspan="1" colspan="1">3</td>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_2 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_3 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_4 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" valign="middle" align="left" rowspan="1" colspan="1">1</td>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_5 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" valign="middle" align="left" rowspan="1" colspan="1">0</td>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_6 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" valign="middle" align="left" rowspan="1" colspan="1">8</td>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_7 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" valign="middle" align="left" rowspan="1" colspan="1">1</td>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_8 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" valign="middle" align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>Noonan-syndrome-like facies</bold>
                  </td>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_1 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" valign="middle" align="left" rowspan="1" colspan="1">5</td>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_2 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_3 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_4 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" valign="middle" align="left" rowspan="1" colspan="1">1</td>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_5 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_6 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" valign="middle" align="left" rowspan="1" colspan="1">12</td>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_7 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" valign="middle" align="left" rowspan="1" colspan="1">1</td>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_8 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" valign="middle" align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>Pectus anomalies</bold>
                  </td>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_1 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" valign="middle" align="left" rowspan="1" colspan="1">3</td>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_2 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_3 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_4 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" valign="middle" align="left" rowspan="1" colspan="1">3</td>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_5 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_6 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" valign="middle" align="left" rowspan="1" colspan="1">7</td>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_7 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" valign="middle" align="left" rowspan="1" colspan="1">1</td>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_8 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" valign="middle" align="left" rowspan="1" colspan="1">1</td>
                </tr>
                <tr>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>Depigmented macules</bold>
                  </td>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_1 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" valign="middle" align="left" rowspan="1" colspan="1">3</td>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_2 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_3 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_4 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" valign="middle" align="left" rowspan="1" colspan="1">1</td>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_5 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_6 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_7 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_8 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" valign="middle" align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>Vascular lesions</bold>
                  </td>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_1 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" valign="middle" align="left" rowspan="1" colspan="1">1</td>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_2 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_3 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" valign="middle" align="left" rowspan="1" colspan="1">1</td>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_4 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" valign="middle" align="left" rowspan="1" colspan="1">2</td>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_5 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_6 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_7 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_8 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" valign="middle" align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>Lipomas</bold>
                  </td>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_1 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" valign="middle" align="left" rowspan="1" colspan="1">14</td>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_2 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" valign="middle" align="left" rowspan="1" colspan="1">2</td>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_3 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_4 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" valign="middle" align="left" rowspan="1" colspan="1">2&#x000a0;<sup>3</sup></td>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_5 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_6 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" valign="middle" align="left" rowspan="1" colspan="1">2</td>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_7 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" valign="middle" align="left" rowspan="1" colspan="1">1</td>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_8 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" valign="middle" align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>Learning disabilities / ADHD / developmental delays</bold>
                  </td>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_1 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" valign="middle" align="left" rowspan="1" colspan="1">8</td>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_2 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" valign="middle" align="left" rowspan="1" colspan="1">5</td>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_3 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_4 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" valign="middle" align="left" rowspan="1" colspan="1">9</td>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_5 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" valign="middle" align="left" rowspan="1" colspan="1">2</td>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_6 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" valign="middle" align="left" rowspan="1" colspan="1">16</td>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_7 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" valign="middle" align="left" rowspan="1" colspan="1">4</td>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_8 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" valign="middle" align="left" rowspan="1" colspan="1">6</td>
                </tr>
                <tr>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>Headaches</bold>
                  </td>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_1 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_2 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" valign="middle" align="left" rowspan="1" colspan="1">4</td>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_3 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_4 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_5 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_6 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" valign="middle" align="left" rowspan="1" colspan="1">2</td>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_7 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_8 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" valign="middle" align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>Hearing loss</bold>
                  </td>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_1 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_2 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_3 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_4 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" valign="middle" align="left" rowspan="1" colspan="1">2</td>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_5 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_6 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" valign="middle" align="left" rowspan="1" colspan="1">1</td>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_7 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_8 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" valign="middle" align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>Seizures</bold>
                  </td>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_1 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_2 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_3 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_4 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" valign="middle" align="left" rowspan="1" colspan="1">2</td>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_5 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_6 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" valign="middle" align="left" rowspan="1" colspan="1">1</td>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_7 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_8 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" valign="middle" align="left" rowspan="1" colspan="1">1</td>
                </tr>
                <tr>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>Polydactyly</bold>
                  </td>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_1 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_2 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_3 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_4 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" valign="middle" align="left" rowspan="1" colspan="1">1</td>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_5 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_6 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" valign="middle" align="left" rowspan="1" colspan="1">2</td>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_7 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_8 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" valign="middle" align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>Scoliosis</bold>
                  </td>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_1 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_2 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_3 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_4 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_5 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_6 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" valign="middle" align="left" rowspan="1" colspan="1">4</td>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_7 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_8 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" valign="middle" align="left" rowspan="1" colspan="1">1</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn>
                <p>ADHD = attention deficit hyperactivity disorder</p>
              </fn>
              <fn id="legius.TF.2.1">
                <label>1. </label>
                <p>Clinical cohort (cohort 1). Data from Anonymous cohort are not included due to potential overlap.</p>
              </fn>
              <fn id="legius.TF.2.2">
                <label>2. </label>
                <p>Absence of clinical findings was not always reported; hence, numbers represent only data that were reported in the respective articles.</p>
              </fn>
              <fn id="legius.TF.2.3">
                <label>3. </label>
                <p>Includes angiolipoma</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <p><bold>Tumor risk.</bold> Legius syndrome in general lacks the tumor manifestations typically observed in NF1 (i.e., Lisch nodules, neurofibromas, and central nervous system tumors). One group has suggested that individuals with Legius syndrome are at an increased risk for leukemia [<xref ref-type="bibr" rid="legius.REF.pasmant.2009.1131">Pasmant et al 2009</xref>, <xref ref-type="bibr" rid="legius.REF.pasmant.2015.631">Pasmant et al 2015</xref>]. There has been a report of acute myeloblastic leukemia in one individual by <xref ref-type="bibr" rid="legius.REF.pasmant.2009.1131">Pasmant et al [2009]</xref>, and this group subsequently screened 230 pediatric lymphoblastic and acute myeloblastic leukemias and found a loss-of-function frameshift <italic toggle="yes">SPRED1</italic> variant in a patient with Legius syndrome, but no other <italic toggle="yes">SPRED1</italic> pathogenic variant in the cohort [<xref ref-type="bibr" rid="legius.REF.pasmant.2015.631">Pasmant et al 2015</xref>]. However, in the one patient, the karyotype of white blood cell blasts showed a <italic toggle="yes">SPRED1</italic> loss of heterozygosity [<xref ref-type="bibr" rid="legius.REF.pasmant.2015.631">Pasmant et al 2015</xref>]. In addition, SPRED1 protein and <italic toggle="yes">SPRED1</italic> mRNA levels were decreased in the majority of acute myeloblastic leukemias at diagnosis [<xref ref-type="bibr" rid="legius.REF.pasmant.2015.631">Pasmant et al 2015</xref>]. Further studies are needed to assess the potential risk for cancers in Legius syndrome, particularly given that <italic toggle="yes">SPRED1</italic> is part of the RAS-MAPK signal transduction pathway, a pathway involved in several neoplasms.</p>
        </sec>
        <sec id="legius.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p>To date no genotype-phenotype correlations have been documented.</p>
        </sec>
        <sec id="legius.Penetrance">
          <title>Penetrance</title>
          <p>The vast majority of individuals with <italic toggle="yes">SPRED1</italic> pathogenic variants have caf&#x000e9; au lait macules and/or freckling; however, the age of pigment penetrance is not established. Only two individuals (a 60-year-old male and a 2-year-old child), each with a presumed <italic toggle="yes">SPRED1</italic> pathogenic variant, were reported not to have caf&#x000e9; au lait macules or freckling [<xref ref-type="bibr" rid="legius.REF.brems.2007.1120">Brems et al 2007</xref>, <xref ref-type="bibr" rid="legius.REF.messiaen.2009.2111">Messiaen et al 2009</xref>].</p>
        </sec>
        <sec id="legius.Anticipation">
          <title>Anticipation</title>
          <p>No evidence for anticipation exists.</p>
        </sec>
        <sec id="legius.Nomenclature">
          <title>Nomenclature</title>
          <p>Individuals with <italic toggle="yes">SPRED1</italic> pathogenic variants were initially described as having &#x0201c;neurofibromatosis type 1-like syndrome&#x0201d; (NFLS) &#x02013; primarily because of the observation that the findings in many fulfilled the current NIH NF1 clinical diagnostic criteria, even though based solely on pigmentary findings [<xref ref-type="bibr" rid="legius.REF.brems.2007.1120">Brems et al 2007</xref>]. Although <italic toggle="yes">NF1</italic> and <italic toggle="yes">SPRED1</italic> interact within the same signal transduction pathway, the majority of individuals with <italic toggle="yes">SPRED1</italic> pathogenic variants share the pigmentary manifestations but lack the tumor findings associated with NF1. To clearly delineate this point in counseling sessions and to avoid confusion between NF1 and NF1-like syndrome, experts at the 13th European Neurofibromatosis Meeting (2008) suggested that the disorder be named &#x0201c;Legius syndrome&#x0201d; after Eric Legius, the senior author of the publication that first described the phenotype of <italic toggle="yes">SPRED1</italic> pathogenic variants in humans [<xref ref-type="bibr" rid="legius.REF.brems.2007.1120">Brems et al 2007</xref>].</p>
        </sec>
        <sec id="legius.Prevalence">
          <title>Prevalence</title>
          <p>The prevalence of Legius syndrome is not known, but in two studies approximately 2% of individuals fulfilling diagnostic criteria for NF1 have had <italic toggle="yes">SPRED1</italic> pathogenic variants [<xref ref-type="bibr" rid="legius.REF.messiaen.2009.2111">Messiaen et al 2009</xref>, <xref ref-type="bibr" rid="legius.REF.muramzborovski.2010.1203">Muram-Zborovski et al 2010</xref>]. The incidence of NF1 is reported to be 1:3000 [<xref ref-type="bibr" rid="legius.REF.friedman.1997.138">Friedman &#x00026; Birch 1997</xref>].</p>
        </sec>
      </sec>
      <sec id="legius.Genetically_Related_Allelic_Disor">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>No phenotypes other than those discussed in this <italic toggle="yes">GeneReview</italic> are known to be associated with mutation of <italic toggle="yes">SPRED1.</italic></p>
      </sec>
      <sec id="legius.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Of primary importance in the clinical delineation of Legius syndrome is establishing the absence of other manifestations associated with the large number of other syndromes with multiple caf&#x000e9; au lait macules. Although the diagnosis of Legius syndrome is difficult to make clinically with certainty without identification of a <italic toggle="yes">SPRED1</italic> pathogenic variant, the lack of additional clinical features, especially in older individuals, can help to differentiate Legius syndrome from other conditions.</p>
        <p><related-object link-type="booklink" source-id="gene" document-id="nf1" document-type="chapter"><bold>Neurofibromatosis 1</bold></related-object>
<bold>(NF1)</bold> is most frequently confused with Legius syndrome, as some individuals with Legius syndrome fulfill the clinical diagnostic criteria for NF1 [<xref ref-type="bibr" rid="legius.REF.nih.1988.172">NIH 1988</xref>, <xref ref-type="bibr" rid="legius.REF.gutmann.1997.51">Gutmann et al 1997</xref>]. Approximately 3%-25% of individuals being evaluated for NF1 who do not have an identifiable <italic toggle="yes">NF1</italic> pathogenic variant have a <italic toggle="yes">SPRED1</italic> pathogenic variant [<xref ref-type="bibr" rid="legius.REF.brems.2007.1120">Brems et al 2007</xref>, <xref ref-type="bibr" rid="legius.REF.messiaen.2009.2111">Messiaen et al 2009</xref>, <xref ref-type="bibr" rid="legius.REF.pasmant.2009.1131">Pasmant et al 2009</xref>, <xref ref-type="bibr" rid="legius.REF.spurlock.2009.431">Spurlock et al 2009</xref>]. The vast majority of individuals with NF1 eventually develop Lisch nodules and neurofibromas, but these manifestations are age-related, making the clinical distinction of NF1 from Legius syndrome very difficult in young children. The non-pigmentary manifestations outlined in the NIH NF1 diagnostic criteria (e.g., Lisch nodules, neurofibromas, optic pathway gliomas, sphenoid wing dysplasia, long-bone dysplasia) have not been observed in individuals with Legius syndrome, and the presence of one of these manifestations differentiates NF1 from Legius syndrome. Caution is needed when trying to establish a diagnosis of NF1 based purely on pigmentary findings [<xref ref-type="bibr" rid="legius.REF.stevenson.2009.2150">Stevenson &#x00026; Viskochil 2009</xref>].</p>
        <p>The phenotypes associated with specific <italic toggle="yes">NF1</italic> pathogenic variants are similar to Legius syndrome in many cases. A described genotype-phenotype correlation with the <italic toggle="yes">NF1</italic> three-base-pair deletion resulting in removal of a methionine residue (c.2970_2972delAAT in exon 22 using NCBI nomenclature) results in an attenuated NF1 phenotype with relative lack of neurofibromas [<xref ref-type="bibr" rid="legius.REF.stevenson.2006.246">Stevenson et al 2006</xref>, <xref ref-type="bibr" rid="legius.REF.upadhyaya.2007.140">Upadhyaya et al 2007</xref>]. An <italic toggle="yes">NF1</italic> pathogenic missense variant (p.Leu1390Phe) was observed in a single multigenerational family that lacked neurofibromas and had features of Noonan syndrome with variable presence of Lisch nodules; however, the possible contribution of other modifiers cannot be excluded [<xref ref-type="bibr" rid="legius.REF.nystr_m.2009a.524">Nystr&#x000f6;m et al 2009a</xref>].</p>
        <p><related-object link-type="booklink" source-id="gene" document-id="noonan" document-type="chapter"><bold>Noonan syndrome</bold></related-object><bold>.</bold> While individuals with Noonan syndrome occasionally have caf&#x000e9; au lait macules, they do not typically have them in large numbers. Some individuals with <italic toggle="yes">SPRED1</italic> pathogenic variants have been reported to have facial features consistent with Noonan syndrome, and at least one individual with Legius syndrome was previously diagnosed as having Noonan syndrome [<xref ref-type="bibr" rid="legius.REF.brems.2007.1120">Brems et al 2007</xref>]. Congenital heart disease is common in Noonan syndrome but has not been a consistent finding in Legius syndrome.</p>
        <p><bold>Autosomal dominant caf&#x000e9; au lait spots</bold> (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/114030">114030</ext-link>). Several families with multiple caf&#x000e9; au lait macules inherited in an autosomal dominant pattern have been described [<xref ref-type="bibr" rid="legius.REF.brunner.1993.472">Brunner et al 1993</xref>, <xref ref-type="bibr" rid="legius.REF.charrow.1993.606">Charrow et al 1993</xref>, <xref ref-type="bibr" rid="legius.REF.arnsmeier.1994.1425">Arnsmeier et al 1994</xref>, <xref ref-type="bibr" rid="legius.REF.abeliovich.1995.985">Abeliovich et al 1995</xref>, <xref ref-type="bibr" rid="legius.REF.nystr_m.2009b.693">Nystr&#x000f6;m et al 2009b</xref>]. It is possible that some of these families harbor a <italic toggle="yes">SPRED1</italic> pathogenic variant, although this phenotype in at least one family did not segregate with markers within the SPRED1 locus [<xref ref-type="bibr" rid="legius.REF.nystr_m.2009b.693">Nystr&#x000f6;m et al 2009b</xref>].</p>
        <p>Other conditions associated with multiple caf&#x000e9; au lait macules include multiple lentigines syndrome (also known as <related-object link-type="booklink" source-id="gene" document-id="leopard" document-type="chapter">LEOPARD syndrome</related-object>), <related-object link-type="booklink" source-id="gene" document-id="mccune-albright" document-type="chapter">McCune-Albright syndrome</related-object>, homozygous mismatch repair cancer syndrome (see <related-object link-type="booklink" source-id="gene" document-id="hnpcc" document-type="chapter">Hereditary Non-Polyposis Colon Cancer</related-object>), <related-object link-type="booklink" source-id="gene" document-id="bloom" document-type="chapter">Bloom syndrome</related-object>, <related-object link-type="booklink" source-id="gene" document-id="fa" document-type="chapter">Fanconia anemia</related-object>, <related-object link-type="booklink" source-id="gene" document-id="rss" document-type="chapter">Russell-Silver syndrome</related-object>, Bannayan-Riley-Ruvalcaba syndrome (see <related-object link-type="booklink" source-id="gene" document-id="phts" document-type="chapter"><italic toggle="yes">PTEN</italic> Hamartoma Tumor Syndrome</related-object>), <related-object link-type="booklink" source-id="gene" document-id="costello" document-type="chapter">Costello syndrome</related-object>, <related-object link-type="booklink" source-id="gene" document-id="cfc" document-type="chapter">cardiofaciocutaneous syndrome</related-object>, and <related-object link-type="booklink" source-id="gene" document-id="tuberous-sclerosis" document-type="chapter">tuberous sclerosis complex</related-object>.</p>
      </sec>
      <sec id="legius.Management">
        <title>Management</title>
        <sec id="legius.Evaluations_Following_Initial_Dia">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs of an individual with a confirmed molecular diagnosis of Legius syndrome, the following evaluations are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p>Age-appropriate developmental assessment</p>
            </list-item>
            <list-item>
              <p>Neuropsychiatric evaluation on entry into school system or sooner based on clinical findings</p>
            </list-item>
            <list-item>
              <p>Detailed dermatologic evaluation for supportive findings</p>
            </list-item>
            <list-item>
              <p>Clinical genetics consultation</p>
            </list-item>
          </list>
        </sec>
        <sec id="legius.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p>The following are appropriate:</p>
          <list list-type="bullet">
            <list-item>
              <p>Consideration of behavioral modification or pharmacologic adjuvant therapy for individuals with ADHD</p>
            </list-item>
            <list-item>
              <p>Adjuvant therapies such as physical, speech, and occupational therapy for individuals with identified developmental delays</p>
            </list-item>
            <list-item>
              <p>Individualized education plans for learning disorders and school performance issues</p>
            </list-item>
          </list>
        </sec>
        <sec id="legius.Prevention_of_Secondary_Complicat">
          <title>Prevention of Secondary Complications</title>
          <p>Age-appropriate developmental assessment and neuropsychiatric evaluations could potentially result in the initiation of therapies to prevent developmental and behavioral complications.</p>
        </sec>
        <sec id="legius.Surveillance">
          <title>Surveillance</title>
          <p>Consider periodic evaluation by a clinical geneticist to discuss manifestations associated with disorders of the Ras/MAPK pathway that may eventually be associated with Legius syndrome</p>
          <p>Routine screening for developmental delays and behavioral and learning problems is appropriate.</p>
          <p>Although vascular abnormalities have been reported in a few individuals with Legius syndrome, hypertension has not been reported. However, given the prevalence of vascular abnormalities and hypertension in NF1, it would seem appropriate to have regular blood pressure monitoring at each physician visit.</p>
        </sec>
        <sec id="legius.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>Using molecular genetic testing for the <italic toggle="yes">SPRED1</italic> pathogenic variant found in the proband, it is appropriate to evaluate relatives at risk (e.g., parents, younger and older sibs of a proband) with caf&#x000e9; au lait macules to identify as early as possible those who could benefit from institution of treatment and preventive measures.</p>
          <p>See <xref ref-type="sec" rid="legius.Related_Genetic_Counseling_Issues">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="legius.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p>
        </sec>
      </sec>
      <sec id="legius.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="legius.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>Legius syndrome is inherited in an autosomal dominant manner.</p>
        </sec>
        <sec id="legius.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Many individuals diagnosed with Legius syndrome have an affected parent.</p>
            </list-item>
            <list-item>
              <p>A proband with Legius syndrome may have the disorder as the result of a <italic toggle="yes">de novo</italic> pathogenic variant. Because the majority of simplex cases (i.e., a single occurrence in a family) have not been evaluated sufficiently to determine if the pathogenic variant occurred <italic toggle="yes">de novo</italic>, the proportion of Legius syndrome caused by <italic toggle="yes">de novo</italic> pathogenic variants is not well elucidated. However, one report states that six of 23 probands with <italic toggle="yes">SPRED1</italic> pathogenic variants in a clinical cohort had <italic toggle="yes">de novo</italic> variants [<xref ref-type="bibr" rid="legius.REF.messiaen.2009.2111">Messiaen et al 2009</xref>].</p>
            </list-item>
            <list-item>
              <p>If the pathogenic variant found in the proband cannot be detected in leukocyte DNA of either parent, two possible explanations are germline mosaicism in a parent or a <italic toggle="yes">de novo</italic> pathogenic variant in the proband. Although no instances of germline mosaicism have been reported, as with any autosomal dominant condition, it remains a possibility.</p>
            </list-item>
            <list-item>
              <p>The family history of some individuals diagnosed with Legius syndrome may appear to be negative because of failure to recognize the disorder in family members, early death of the parent before the onset of symptoms, or late onset of the disease in the affected parent. Therefore, an apparently negative family history cannot be confirmed unless physical examination by a clinical geneticist and <italic toggle="yes">SPRED1</italic> molecular genetic testing has been performed on the parents of the proband.</p>
            </list-item>
          </list>
          <p>Note: If the parent is the individual in whom the pathogenic variant first occurred s/he may have somatic mosaicism for the pathogenic variant and may be mildly/minimally affected, although this has not been reported to date for Legius syndrome.</p>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The risk to the sibs of the proband depends on the genetic status of the proband&#x02019;s parents.</p>
            </list-item>
            <list-item>
              <p>If a parent of the proband is affected, the risk to the sibs is 50%.</p>
            </list-item>
            <list-item>
              <p>When the parents are clinically unaffected, the risk to the sibs of a proband appears to be low.</p>
            </list-item>
            <list-item>
              <p>The sibs of a proband with clinically unaffected parents are still at increased risk for Legius syndrome because of the possibility of reduced penetrance in a parent.</p>
            </list-item>
            <list-item>
              <p>If the <italic toggle="yes">SPRED1</italic> pathogenic variant found in the proband cannot be detected in the leukocyte DNA of either parent, the risk to sibs is low, but greater than that of the general population because of the possibility of germline mosaicism.</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> Each child of an individual with Legius syndrome has a 50% chance of inheriting the <italic toggle="yes">SPRED1</italic> pathogenic variant.</p>
          <p>
            <bold>Other family members</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The risk to other family members depends on the status of the proband's parents.</p>
            </list-item>
            <list-item>
              <p>If a parent is affected, his or her family members may be at risk.</p>
            </list-item>
          </list>
        </sec>
        <sec id="legius.Related_Genetic_Counseling_Issues">
          <title>Related Genetic Counseling Issues</title>
          <p>See Management, <xref ref-type="sec" rid="legius.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</xref> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p>
          <p><bold>Considerations in families with an apparent <italic toggle="yes">de novo</italic> pathogenic variant.</bold> When neither parent of a proband with Legius syndrome has the pathogenic variant or clinical evidence of the disorder, it is likely that the variant occurred <italic toggle="yes">de novo</italic> in the proband. However, possible non-medical explanations including alternate paternity or maternity (e.g., with assisted reproduction) or undisclosed adoption could also be explored.</p>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected or at risk.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="legius.Prenatal_Testing_and_Preimplantat">
          <title>Prenatal Testing and Preimplantation Genetic Diagnosis</title>
          <p>Once the <italic toggle="yes">SPRED1</italic> pathogenic variant has been identified in an affected family member, prenatal testing for a pregnancy at increased risk and preimplantation genetic diagnosis for Legius syndrome are possible.</p>
          <p>Requests for prenatal testing for conditions which (like Legius syndrome) do not affect intellect and have some treatment available are not common. Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. Although most centers would consider decisions about prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p>
        </sec>
      </sec>
      <sec id="legius.Resources">
        <title>Resources</title>
      </sec>
      <sec id="legius.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <sec id="legius.Molecular_Genetic_Pathogenesis">
          <title>Molecular Genetic Pathogenesis</title>
          <p><italic toggle="yes">SPRED1</italic> encodes a protein that negatively regulates Ras-MAPK signaling. Pathogenic loss-of-function variants in <italic toggle="yes">SPRED1</italic> create mutated Spred1 proteins incapable of inhibiting Raf1 kinase activation. This results in attenuated inhibition of downstream Raf-MEK-ERK signaling [<xref ref-type="bibr" rid="legius.REF.brems.2007.1120">Brems et al 2007</xref>]. This uninhibited signaling and consequent increase in Ras signal propagation is similar to that observed in NF1 and likely results in the clinical overlap of these two conditions.</p>
          <p>For example, neurobehavioral problems are reported in individuals with Legius syndrome and NF1; this finding in Legius syndrome is biologically consistent with data in the mouse model showing that Spred1 protein is required for synaptic plasticity [<xref ref-type="bibr" rid="legius.REF.denayer.2008.14443">Denayer et al 2008</xref>]. In addition, vascular anomalies are seen in other syndromes of the Ras-MAPK pathway (i.e., capillary malformation-arteriovenous malformation syndrome with <italic toggle="yes">RASA1</italic> pathogenic variants), providing potential biologic support for an association with Legius syndrome.</p>
          <p><bold>Gene structure</bold>. <italic toggle="yes">SPRED1</italic> spans 104.4 kb of genomic sequence. It consists of seven exons. The transcript is 7255 bp in length (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/187169267">NM_152594.2</ext-link>) and encodes 444 amnio acids (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/22749221">NP_689807.1</ext-link>). For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="legius" object-id="legius.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
          <p><bold>Benign variants.</bold> Twenty-four benign or suspected benign variants have been reported in two locus-specific databases. Ten are missense variants, eleven are silent variants, and three are spice site variants.</p>
          <p><xref ref-type="bibr" rid="legius.REF.muramzborovski.2010.1203">Muram-Zborovski et al [2010]</xref> identified a common <italic toggle="yes">SPRED1</italic> haplotype matching GenBank reference sequence <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NG_008980">NG_008980</ext-link> in 17.9% of their NF1 cohort and 12.5% of an unselected normal population. This haplotype differs from the more common reference sequence <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NC_000015">NC_000015</ext-link> by four single-nucleotide variants. Two of these normal variants are in exons, one in exon 3 and one in exon 7; the other two SNPs are within intron 5. See <xref ref-type="table" rid="legius.T.selected_spred1_benign_variants">Table 3</xref>.</p>
          <table-wrap id="legius.T.selected_spred1_benign_variants" orientation="portrait" position="anchor">
            <label>Table 3. </label>
            <caption>
              <p>Selected <italic toggle="yes">SPRED1</italic> Benign Variants</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_legius.T.selected_spred1_benign_variants_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                  <th id="hd_h_legius.T.selected_spred1_benign_variants_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                  <th id="hd_h_legius.T.selected_spred1_benign_variants_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_legius.T.selected_spred1_benign_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.291A&#x0003e;G</td>
                  <td headers="hd_h_legius.T.selected_spred1_benign_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Lys97Lys</td>
                  <td headers="hd_h_legius.T.selected_spred1_benign_variants_1_1_1_3" rowspan="4" valign="middle" align="left" colspan="1">
                    <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/187169267">NM_152594.2</ext-link>
                    <break/>
                    <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/22749221">NP_689807.1</ext-link>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_legius.T.selected_spred1_benign_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1044C&#x0003e;T</td>
                  <td headers="hd_h_legius.T.selected_spred1_benign_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Val348Val</td>
                </tr>
                <tr>
                  <td headers="hd_h_legius.T.selected_spred1_benign_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.424-8A&#x0003e;C</td>
                  <td headers="hd_h_legius.T.selected_spred1_benign_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">NA</td>
                </tr>
                <tr>
                  <td headers="hd_h_legius.T.selected_spred1_benign_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.424-98C&#x0003e;T</td>
                  <td headers="hd_h_legius.T.selected_spred1_benign_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">NA</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn>
                <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
              </fn>
              <fn>
                <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
              </fn>
              <fn>
                <p>NA = not applicable</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <p><bold>Pathogenic variants.</bold> Pathogenic variants have been identified throughout <italic toggle="yes">SPRED1</italic>, without a discernible mutational hotspot. Most of the pathogenic variants identified are nonsense variants, splice site variants, small insertions/deletions, and gross gene rearrangements. They are predicted to be protein truncating. A few missense variants have also been identified within families; however, only a portion of these have been confirmed as pathogenic using functional studies [<xref ref-type="bibr" rid="legius.REF.messiaen.2009.2111">Messiaen et al 2009</xref>].</p>
          <p><bold>Normal gene product.</bold> Spred1 protein is a 444-amino acid sprouty-related protein. It comprises an N-terminal EVH-1 domain, a central KIT binding domain, and a C-terminal SPRY domain. Spred1 belongs to a family of proteins that are negative regulators of the Ras/ERK pathway. Spred1 negatively regulates the Ras/ERK pathway by inhibiting Raf1 kinase activation [<xref ref-type="bibr" rid="legius.REF.wakioka.2001.647">Wakioka et al 2001</xref>, <xref ref-type="bibr" rid="legius.REF.tidyman.2009.230">Tidyman &#x00026; Rauen 2009</xref>]. Spred1 has also been shown to interact with neurofibromin to bring it to plasma membrane-bound Ras peptides [<xref ref-type="bibr" rid="legius.REF.stowe.2012.1421">Stowe et al 2012</xref>].</p>
          <p><bold>Abnormal gene product.</bold> Pathogenic variants in <italic toggle="yes">SPRED1</italic> that result in Spred1 loss of function disrupt its ability to inhibit Raf1 kinase activation, leading to increased downstream ERK signaling. Pathogenic variants in <italic toggle="yes">SPRED1</italic> have been identified within the N-terminal EVH-1 domain, the KIT binding domain, and the C-terminal SPRY domain of the spred1 protein.</p>
        </sec>
      </sec>
      <sec id="legius.References">
        <title>References</title>
        <sec id="legius.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="legius.Literature_Cited.reflist0">
            <ref id="legius.REF.abeliovich.1995.985">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Abeliovich</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gelman-Kohan</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Silverstein</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lerer</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chemke</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Merin</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zlotogora</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>1995</year>
                <article-title>Familial cafe au lait spots: a variant of neurofibromatosis type 1.</article-title>
                <source>J Med Genet</source>
                <volume>32</volume>
                <fpage>985</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">8825931</pub-id>
              </element-citation>
            </ref>
            <ref id="legius.REF.arnsmeier.1994.1425">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Arnsmeier</surname>
                    <given-names>SL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Riccardi</surname>
                    <given-names>VM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Paller</surname>
                    <given-names>AS</given-names>
                  </name>
                </person-group>
                <year>1994</year>
                <article-title>Familial multiple caf&#x000e9; au lait spots.</article-title>
                <source>Arch Dermatol</source>
                <volume>130</volume>
                <fpage>1425</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">7979446</pub-id>
              </element-citation>
            </ref>
            <ref id="legius.REF.brems.2007.1120">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Brems</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chmara</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sahbatou</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Denayer</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taniguchi</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kato</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Somers</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Messiaen</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Schepper</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fryns</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cools</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marynen</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thomas</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yoshimura</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Legius</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Germline loss-of-function mutations in SPRED1 cause a neurofibromatosis 1-like phenotype.</article-title>
                <source>Nat Genet</source>
                <volume>39</volume>
                <fpage>1120</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">17704776</pub-id>
              </element-citation>
            </ref>
            <ref id="legius.REF.brems.2012.1538">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Brems</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pasmant</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Minkelen</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wimmer</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Upadhyaya</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Legius</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Messiaen</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <article-title>Review and update of SPRED1 mutations causing Legius syndrome.</article-title>
                <source>Hum Mutat.</source>
                <year>2012</year>
                <month>Nov</month>
                <volume>33</volume>
                <issue>11</issue>
                <fpage>1538</fpage>
                <lpage>46</lpage>
                <pub-id pub-id-type="pmid">22753041</pub-id>
              </element-citation>
            </ref>
            <ref id="legius.REF.brunner.1993.472">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Brunner</surname>
                    <given-names>HG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hulsebos</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steijlen</surname>
                    <given-names>PM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>der Kinderen</surname>
                    <given-names>DJ</given-names>
                  </name>
                </person-group>
                <article-title>vd Steen A, Hamel BC. Exclusion of the neurofibromatosis 1 locus in a family with inherited caf&#x000e9;-au-lait spots.</article-title>
                <source>Am J Med Genet.</source>
                <year>1993</year>
                <month>Jun</month>
                <day>1</day>
                <volume>46</volume>
                <issue>4</issue>
                <fpage>472</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">8357027</pub-id>
              </element-citation>
            </ref>
            <ref id="legius.REF.charrow.1993.606">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Charrow</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Listernick</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ward</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>1993</year>
                <article-title>Autosomal dominant multiple caf&#x000e9;-au-lait spots and neurofibromatosis-1: evidence of non-linkage.</article-title>
                <source>Am J Med Genet</source>
                <volume>45</volume>
                <fpage>606</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">8456833</pub-id>
              </element-citation>
            </ref>
            <ref id="legius.REF.denayer.2008.14443">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Denayer</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ahmed</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brems</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Woerden</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Borgesius</surname>
                    <given-names>NZ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Callaerts-Vegh</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yoshimura</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hartmann</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elgersma</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>D&#x02019;Hooge</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Legius</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Balschun</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Spred1 is required for synaptic plasticity and hippocampus-dependent learning.</article-title>
                <source>J Neurosci</source>
                <volume>28</volume>
                <fpage>14443</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">19118178</pub-id>
              </element-citation>
            </ref>
            <ref id="legius.REF.denayer.2011a.e1985">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Denayer</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chmara</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brems</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kievit</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Bever</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van den Ouweland</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Minkelen</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Goede-Bolder</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oostenbrink</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lakeman</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beert</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ishizaki</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mori</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Keymolen</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van den Ende</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mangold</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peltonen</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brice</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rankin</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Spaendonck-Zwarts</surname>
                    <given-names>KY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yoshimura</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Legius</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <year>2011a</year>
                <article-title>Legius syndrome in fourteen families.</article-title>
                <source>Hum Mutat.</source>
                <volume>32</volume>
                <fpage>E1985</fpage>
                <lpage>98</lpage>
                <pub-id pub-id-type="pmid">21089071</pub-id>
              </element-citation>
            </ref>
            <ref id="legius.REF.denayer.2011b.123">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Denayer</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Descheemaeker</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stewart</surname>
                    <given-names>DR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Keymolen</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Plasschaert</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ruppert</surname>
                    <given-names>SL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Snow</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thurm</surname>
                    <given-names>AE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Joseph</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fryns</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Legius</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <year>2011b</year>
                <article-title>Observations on intelligence and behavior in 15 patients with Legius syndrome.</article-title>
                <source>Am J Med Genet C Semin Med Genet</source>
                <volume>157C</volume>
                <fpage>123</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">21495177</pub-id>
              </element-citation>
            </ref>
            <ref id="legius.REF.friedman.1997.138">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Friedman</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Birch</surname>
                    <given-names>PH</given-names>
                  </name>
                </person-group>
                <article-title>Type 1 neurofibromatosis: a descriptive analysis of the disorder in 1,728 patients.</article-title>
                <source>Am J Med Genet.</source>
                <year>1997</year>
                <month>May</month>
                <day>16</day>
                <volume>70</volume>
                <issue>2</issue>
                <fpage>138</fpage>
                <lpage>43</lpage>
                <pub-id pub-id-type="pmid">9128932</pub-id>
              </element-citation>
            </ref>
            <ref id="legius.REF.gutmann.1997.51">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gutmann</surname>
                    <given-names>DH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aylsworth</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carey</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Korf</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marks</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pyeritz</surname>
                    <given-names>RE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rubenstein</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Viskochil</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2.</article-title>
                <source>JAMA</source>
                <volume>278</volume>
                <fpage>51</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">9207339</pub-id>
              </element-citation>
            </ref>
            <ref id="legius.REF.laycockvan_spyk.2011.93">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Laycock-van Spyk</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jim</surname>
                    <given-names>HP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thomas</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spurlock</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fares</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Palmer-Smith</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kini</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saggar</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Patton</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mautner</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pilz</surname>
                    <given-names>DT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Upadhyaya</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Identification of five novel SPRED1 germline mutations in Legius syndrome.</article-title>
                <source>Clin Genet</source>
                <volume>80</volume>
                <fpage>93</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">21649642</pub-id>
              </element-citation>
            </ref>
            <ref id="legius.REF.messiaen.2009.2111">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Messiaen</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yao</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brems</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Callens</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sathienkijkanchai</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Denayer</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spencer</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arn</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Babovic-Vuksanovic</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bay</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bobele</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cohen</surname>
                    <given-names>BH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Escobar</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eunpu</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grebe</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Greenstein</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hachen</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Irons</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kronn</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lemire</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leppig</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lim</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McDonald</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Narayanan</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pearn</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pederson</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Powell</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shapiro</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Skidmore</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tegay</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thiese</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zackai</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vijzelaar</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taniguchi</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ayada</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Okamoto</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yoshimura</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Parret</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Korf</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Legius</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Clinical and mutational spectrum of Neurofibromatosis type 1-like syndrome.</article-title>
                <source>JAMA</source>
                <volume>302</volume>
                <fpage>2111</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">19920235</pub-id>
              </element-citation>
            </ref>
            <ref id="legius.REF.muramzborovski.2010.1203">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Muram-Zborovski</surname>
                    <given-names>TM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stevenson</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Viskochil</surname>
                    <given-names>DH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dries</surname>
                    <given-names>DC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilson</surname>
                    <given-names>AR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mao</surname>
                    <given-names>Rong</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>SPRED 1 mutations in a neurofibromatosis clinic.</article-title>
                <source>J Child Neurol.</source>
                <volume>25</volume>
                <fpage>1203</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">20179001</pub-id>
              </element-citation>
            </ref>
            <ref id="legius.REF.nih.1988.172">
              <element-citation publication-type="journal">
                <person-group>
                  <collab>NIH</collab>
                </person-group>
                <article-title>National Institutes of Health Consensus Development Conference Statement: neurofibromatosis. Bethesda, Md, USA, July 13-15, 1987.</article-title>
                <source>Neurofibromatosis.</source>
                <year>1988</year>
                <volume>1</volume>
                <fpage>172</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">3152465</pub-id>
              </element-citation>
            </ref>
            <ref id="legius.REF.nystr_m.2009a.524">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nystr&#x000f6;m</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ekvall</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Allanson</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Edeby</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elinder</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holmstr&#x000f6;m</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bondeson</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anner&#x000e9;n</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>2009a</year>
                <article-title>Noonan syndrome and neurofibromatosis type I in a family with a novel mutation in NF1.</article-title>
                <source>Clin Genet</source>
                <volume>76</volume>
                <fpage>524</fpage>
                <lpage>34</lpage>
                <pub-id pub-id-type="pmid">19845691</pub-id>
              </element-citation>
            </ref>
            <ref id="legius.REF.nystr_m.2009b.693">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nystr&#x000f6;m</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ekvall</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Str&#x000f6;mberg</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holmstr&#x000f6;m</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Theuresson</surname>
                    <given-names>AC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anner&#x000e9;n</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bondeson</surname>
                    <given-names>ML</given-names>
                  </name>
                </person-group>
                <year>2009b</year>
                <article-title>A severe form of Noonan syndrome and autosomal dominant caf&#x000e9;-au-lait spots &#x02013; evidence for different genetic origins.</article-title>
                <source>Acta Paediatr</source>
                <volume>98</volume>
                <fpage>693</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">19120036</pub-id>
              </element-citation>
            </ref>
            <ref id="legius.REF.pasmant.2009.1131">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pasmant</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ballerini</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lapillonne</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Perot</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vidaud</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leverger</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Landman-Parker</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>SPRED1 disorder and predisposition to leukemia in children.</article-title>
                <source>Blood</source>
                <volume>114</volume>
                <fpage>1131</fpage>
                <pub-id pub-id-type="pmid">19643996</pub-id>
              </element-citation>
            </ref>
            <ref id="legius.REF.pasmant.2015.631">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pasmant</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gilbert-Dussardier</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Petit</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Laval</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Luscan</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gruber</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lapillonne</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Deswarte</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goussard</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laurendeau</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uzan</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pflumio</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brizard</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vabres</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Naguibvena</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fasola</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Millot</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Porteu</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vidaud</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Landman-Parker</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ballerini</surname>
                    <given-names>P.</given-names>
                  </name>
                </person-group>
                <article-title>SPRED1, a RAS MAPK pathway inhibitor that causes Legius syndrome, is a tumor suppressor downregulated in paediatric acute myeloblastic leukaemia.</article-title>
                <source>Oncogene.</source>
                <year>2015</year>
                <volume>34</volume>
                <fpage>631</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">24469042</pub-id>
              </element-citation>
            </ref>
            <ref id="legius.REF.spencer.2011.1352">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Spencer</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davis</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mikhail</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fu</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vijzelaar</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zackai</surname>
                    <given-names>EH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Feret</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meyn</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shugar</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bellus</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kocsis</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kivirikko</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>P&#x000f6;yh&#x000f6;nen</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Messiaen</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Identification of SPRED1 deletions using RT-PCR, multiplex ligation-dependent probe amplification and quantitative PCR.</article-title>
                <source>Am J Med Genet A.</source>
                <volume>155A</volume>
                <fpage>1352</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">21548021</pub-id>
              </element-citation>
            </ref>
            <ref id="legius.REF.spurlock.2009.431">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Spurlock</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bennett</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chuzhanova</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thomas</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jim</surname>
                    <given-names>HP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Side</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davies</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haan</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kerr</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huson</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Upadhyaya</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>SPRED1 mtuations (Legius syndrome): another clinically useful genotype for dissecting the NF1 phenotype.</article-title>
                <source>J Med Genet</source>
                <volume>46</volume>
                <fpage>431</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">19443465</pub-id>
              </element-citation>
            </ref>
            <ref id="legius.REF.stevenson.2009.2150">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Stevenson</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Viskochil</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Pigmentary findings in neurofibromatosis type 1-like syndrome (Legius syndrome): potential diagnostic dilemmas.</article-title>
                <source>JAMA</source>
                <year>2009</year>
                <volume>302</volume>
                <fpage>2150</fpage>
                <lpage>1</lpage>
                <pub-id pub-id-type="pmid">19920242</pub-id>
              </element-citation>
            </ref>
            <ref id="legius.REF.stevenson.2006.246">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Stevenson</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Viskochil</surname>
                    <given-names>DH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rope</surname>
                    <given-names>AF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carey</surname>
                    <given-names>JC</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Clinical and molecular aspects of an informative family with neurofibromatosis type 1 and Noonan phenotype.</article-title>
                <source>Clin Genet</source>
                <volume>69</volume>
                <fpage>246</fpage>
                <lpage>53</lpage>
                <pub-id pub-id-type="pmid">16542390</pub-id>
              </element-citation>
            </ref>
            <ref id="legius.REF.stowe.2012.1421">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Stowe</surname>
                    <given-names>IB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mercado</surname>
                    <given-names>EL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stowe</surname>
                    <given-names>TR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bell</surname>
                    <given-names>EL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oses-Prieto</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hern&#x000e1;ndez</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burlingame</surname>
                    <given-names>AL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McCormick</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>A shared molecular mechanism underlies the human rasopathies Legius syndrome and Neurofibormatosis-1.</article-title>
                <source>Genes Dev</source>
                <volume>26</volume>
                <fpage>1421</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">22751498</pub-id>
              </element-citation>
            </ref>
            <ref id="legius.REF.tidyman.2009.230">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tidyman</surname>
                    <given-names>WE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rauen</surname>
                    <given-names>KA</given-names>
                  </name>
                </person-group>
                <article-title>The RASopathies: developmental syndromes of Ras/MAPK pathway dysregulation.</article-title>
                <source>Curr Opin Genet Dev</source>
                <year>2009</year>
                <volume>19</volume>
                <fpage>230</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">19467855</pub-id>
              </element-citation>
            </ref>
            <ref id="legius.REF.upadhyaya.2007.140">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Upadhyaya</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huson</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davies</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thomas</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chuzhanova</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giovannini</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Evans</surname>
                    <given-names>DG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Howard</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kerr</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Griffiths</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Consoli</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Side</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Adams</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pierpoint</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hachen</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barnicoat</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wallace</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stevenson</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Viskochil</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baralle</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haan</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Turnpenny</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Riccardi</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lazaro</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Messiaen</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>An absence of cutaneous neurofibroma associated with a 3-bp in-frame deletion in exon 17 of the NF1 gene (c.2970_2972 delAAT): Evidence of a clinically significant NF1 genotype-phenotype correlation.</article-title>
                <source>Am J Hum Genet</source>
                <volume>80</volume>
                <fpage>140</fpage>
                <lpage>51</lpage>
                <pub-id pub-id-type="pmid">17160901</pub-id>
              </element-citation>
            </ref>
            <ref id="legius.REF.wakioka.2001.647">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wakioka</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sasaki</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kato</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shouda</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matsumoto</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miyoshi</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsuneoka</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Komiya</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baron</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yoshimura</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Spred is a Sprouty-related suppressor of Ras signaling.</article-title>
                <source>Nature</source>
                <volume>412</volume>
                <fpage>647</fpage>
                <lpage>51</lpage>
                <pub-id pub-id-type="pmid">11493923</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="legius.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="legius.Acknowledgments">
          <title>Acknowledgments</title>
          <p>John Carey, MD; Ludwine Messiaen, PhD; Talia Muram, MD</p>
        </sec>
        <sec id="legius.Author_History">
          <title>Author History</title>
          <p>Rong Mao, MD (2010-present)Talia Muram-Zborovski, MD, University of Utah (2010-2015)David Stevenson, MD (2010-present)David Viskochil, MD, PhD (2010-present)</p>
        </sec>
        <sec id="legius.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>15 January 2015 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>12 May 2011 (cd) Revision: Testing Strategy; <xref ref-type="table" rid="legius.T.additional_findings_reported_in">Table 2</xref></p>
            </list-item>
            <list-item>
              <p>14 October 2010 (me) Review posted live</p>
            </list-item>
            <list-item>
              <p>29 April 2010 (ds) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
